MiMedx Can Launch Phase 3 IND Trial for Achilles Tendonitis

FDA granted MiMedx permission to proceed with an Investigational New Drug Phase III clinical trial of AmnioFix® Injectable in the treatment of Achilles Tendonitis. Enrollment of 158 patients will begin in 4Q17.

The prospective, double blinded, randomized controlled trial will compare the Micronized dehydrated Human Amnion Chorion...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us